Parkinson’s disease(PD)is a common neurological disease in elderly people,and its morbidity and mortality are increasing with the advent of global ageing.The traditional paradigm of moving from small data to big data...Parkinson’s disease(PD)is a common neurological disease in elderly people,and its morbidity and mortality are increasing with the advent of global ageing.The traditional paradigm of moving from small data to big data in biomedical research is shifting toward big data-based identification of small actionable alterations.To highlight the use of big data for precision PD medicine,we review PD big data and informatics for the translation of basic PD research to clinical applications.We emphasize some key findings in clinically actionable changes,such as susceptibility genetic variations for PD risk population screening,biomarkers for the diagnosis and stratification of PD patients,risk factors for PD,and lifestyles for the prevention of PD.The challenges associated with the collection,storage,and modelling of diverse big data for PD precision medicine and healthcare are also summarized.Future perspectives on systems modelling and intelligent medicine for PD monitoring,diagnosis,treatment,and healthcare are discussed in the end.展开更多
基金supported by the National Key R&D Program of China(Grant No.2016YFC1306605)the National Natural Science Foundation of China(Grant Nos.31670851,31470821,and 91530320)
文摘Parkinson’s disease(PD)is a common neurological disease in elderly people,and its morbidity and mortality are increasing with the advent of global ageing.The traditional paradigm of moving from small data to big data in biomedical research is shifting toward big data-based identification of small actionable alterations.To highlight the use of big data for precision PD medicine,we review PD big data and informatics for the translation of basic PD research to clinical applications.We emphasize some key findings in clinically actionable changes,such as susceptibility genetic variations for PD risk population screening,biomarkers for the diagnosis and stratification of PD patients,risk factors for PD,and lifestyles for the prevention of PD.The challenges associated with the collection,storage,and modelling of diverse big data for PD precision medicine and healthcare are also summarized.Future perspectives on systems modelling and intelligent medicine for PD monitoring,diagnosis,treatment,and healthcare are discussed in the end.
